This future-facing course explores how next-generation genomics and artificial intelligence are reshaping cancer research and precision oncology, and how the ethical, legal, and social implications of these technologies will shape their responsible use. You will engage with the science that is changing clinical reality, from CRISPR-enabled genome editing and single-cell sequencing to graph genome models and liquid biopsy approaches that can reveal disease biology in real time.
What makes this course distinctive is not only what you learn, but how you learn to think. You will develop the judgement required to evaluate evidence, uncertainty, and real-world impact, especially in areas where scientific possibility moves faster than public trust, regulation, and equity. Through case-led learning and immersive simulations, you will explore how governance frameworks, social justice, and moral responsibility shape what is permissible, what is effective, and what is truly beneficial in precision oncology.
By the end of the programme, you are not simply “trained” in advanced topics. You are supported to think as a responsible innovator, able to work at the intersection of discovery, policy, and human consequence.
Learners explore advanced genomics, AI, and ethical governance through the lens of cancer diagnostics and personalised treatment, including:
Learners also participate in a simulation experience, such as an ethics board hearing, public health tribunal, or global data summit. An optional mini-capstone supports learners in developing a translational innovation proposal or policy brief, with structured feedback where appropriate.
By the end of the course, learners will be able to:
At Afer*Nova, programmes combine academic depth with real-world relevance through a structure designed to support both independence and intellectual mentorship.
Programmes begin with flexible, high-quality learning modules that build a strong conceptual base, including:
Learners engage in mentor-guided workshops focused on applied reasoning, featuring:
These sessions are designed to develop clarity, confidence, collaboration, and decision-making under uncertainty.
Every programme is reviewed periodically to reflect:
This ensures the curriculum remains forward-looking while grounded in responsible scholarship.
This course offers a rare combination: advanced genomic science, AI-enabled medicine, and the ethical reasoning required to lead responsibly in precision oncology. You learn how evidence is generated, contested, and governed, and how decisions are shaped by law, equity, and public accountability.
Learners are supported through structured teaching and mentoring from experienced educators and professionals working across genomics, clinical ethics, and AI-enabled health innovation. Support is provided through guided learning, small-group sessions, and individual feedback where appropriate.
Subject to academic standards and review, learners may also be supported in developing research summaries, abstracts, policy briefs, or innovation proposals suitable for dissemination in appropriate academic or professional settings.
Learners who successfully complete programme requirements receive a certificate of completion. Where appropriate, and subject to meeting defined performance standards, students may be eligible to request a personalised letter of recommendation at the discretion of the supervising academic or clinical advisor.
Important note: dissemination opportunities and recommendation letters are discretionary outcomes and are not guaranteed.
Subject to performance, quality review, and supervision, learners may have the opportunity to:
If you wish to enroll in the course, please click the ‘Register Now’ button. Our team will reach out to you after reviewing your academic qualifications.